SG10201803996WA - Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation - Google Patents
Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparationInfo
- Publication number
- SG10201803996WA SG10201803996WA SG10201803996WA SG10201803996WA SG10201803996WA SG 10201803996W A SG10201803996W A SG 10201803996WA SG 10201803996W A SG10201803996W A SG 10201803996WA SG 10201803996W A SG10201803996W A SG 10201803996WA SG 10201803996W A SG10201803996W A SG 10201803996WA
- Authority
- SG
- Singapore
- Prior art keywords
- granules
- rifapentine
- isoniazid
- preparation
- pharmaceutical composition
- Prior art date
Links
- 239000008187 granular material Substances 0.000 title abstract 6
- 239000007919 dispersible tablet Substances 0.000 title abstract 3
- 229960003350 isoniazid Drugs 0.000 title abstract 3
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- WDZCUPBHRAEYDL-GZAUEHORSA-N rifapentine Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N(CC1)CCN1C1CCCC1 WDZCUPBHRAEYDL-GZAUEHORSA-N 0.000 title abstract 3
- 229960002599 rifapentine Drugs 0.000 title abstract 3
- 230000002365 anti-tubercular Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/06—Phenols the aromatic ring being substituted by nitro groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3342CH2013 | 2013-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201803996WA true SG10201803996WA (en) | 2018-06-28 |
Family
ID=51211798
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201803996WA SG10201803996WA (en) | 2013-07-26 | 2014-07-22 | Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation |
| SG11201510732VA SG11201510732VA (en) | 2013-07-26 | 2014-07-22 | Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201510732VA SG11201510732VA (en) | 2013-07-26 | 2014-07-22 | Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9814680B2 (zh) |
| EP (1) | EP3024444A1 (zh) |
| JP (2) | JP2016539110A (zh) |
| CN (1) | CN105407876B (zh) |
| AU (1) | AU2014295099B2 (zh) |
| CA (1) | CA2918528A1 (zh) |
| CL (1) | CL2016000183A1 (zh) |
| HK (1) | HK1218861A1 (zh) |
| IL (1) | IL243369A0 (zh) |
| MX (1) | MX2016001155A (zh) |
| PE (1) | PE20160245A1 (zh) |
| PH (1) | PH12016500119A1 (zh) |
| RU (1) | RU2694056C2 (zh) |
| SA (1) | SA516370446B1 (zh) |
| SG (2) | SG10201803996WA (zh) |
| TW (1) | TWI630911B (zh) |
| WO (1) | WO2015011162A1 (zh) |
| ZA (1) | ZA201600110B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2672879C2 (ru) | 2013-07-26 | 2018-11-20 | Санофи | Противотуберкулезная композиция, содержащая рифампицин, изониазид, этамбутол и пиразинамид, и способ ее получения |
| JP2023549126A (ja) * | 2020-11-09 | 2023-11-22 | レアルタ ライフ サイエンシズ インコーポレイテッド | ペプチド製剤および使用方法 |
| CN112730657A (zh) * | 2020-12-18 | 2021-04-30 | 卓和药业集团有限公司 | 利福喷丁含量的分析检测方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1217912A (zh) * | 1997-11-26 | 1999-06-02 | 岑冠新 | 复方利福喷丁制剂及制备方法 |
| NZ518216A (en) * | 2000-08-09 | 2004-11-26 | Panacea Biotec Ltd | Pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
| AU2001294250A1 (en) * | 2000-10-16 | 2002-04-29 | Daiichi Pharmaceutical Co., Ltd. | Medicinal compositions quickly disintegrating in the oral cavity and process forproducing the same |
| WO2002087547A1 (en) | 2001-04-27 | 2002-11-07 | Lupin Limited | An improved process for preparation of four-drug anti-tubercular fixed dose combination |
| US20050059719A1 (en) | 2003-09-16 | 2005-03-17 | Badawy Sherif Ibrahim Farag | Solid dosage formulation containing a Factor Xa inhibitor and method |
| TWI368509B (en) | 2005-10-05 | 2012-07-21 | Otsuka Pharma Co Ltd | Antituberculous therapeutic drugs and kit containing the same |
| JP5105818B2 (ja) * | 2005-10-05 | 2012-12-26 | 大塚製薬株式会社 | 医薬組成物 |
| US20090295921A1 (en) * | 2005-10-12 | 2009-12-03 | Pioneer Corporation | Vehicle-mounted photographing device and method of measuring photographable range of vehicle-mounted camera |
| CN1989966B (zh) | 2005-12-30 | 2011-06-08 | 重庆华邦制药股份有限公司 | 含利福平和异烟肼的药物组合物 |
| CN1857280A (zh) * | 2006-04-11 | 2006-11-08 | 济南帅华医药科技有限公司 | 一种复方抗结核药物缓释制剂 |
| US20090181080A1 (en) * | 2007-08-06 | 2009-07-16 | Insys Therapeutics Inc. | Oral cannabinnoid liquid formulations and methods of treatment |
| KR101197277B1 (ko) * | 2009-02-05 | 2012-11-05 | (주) 벡스코아 | 경구용 결핵의 치료용 또는 예방용 고형 제형 |
| AP2012006119A0 (en) | 2009-07-31 | 2012-02-29 | Cadila Pharmaceuticals Ltd | Pharmaceutical composition of isoniazid. |
| US20130129791A1 (en) * | 2010-05-04 | 2013-05-23 | Mahmut Bilgic | Preparations of effervescent formulations comprising second and third generation cephalosporin and uses thereof |
| WO2012013756A2 (fr) | 2010-07-28 | 2012-02-02 | Laboratoires Pharma 5 | Procédé de préparation de comprimés contenant en association la rifampicine, l'isoniazide, la pyrazinamide, et éventuellement l'ethambutol |
| US8470365B2 (en) * | 2010-07-29 | 2013-06-25 | Taiwan Biotech Co., Ltd. | Process for preparation of anti-tubercular combination and pharmaceutical composition prepared therefrom |
| RU2672879C2 (ru) | 2013-07-26 | 2018-11-20 | Санофи | Противотуберкулезная композиция, содержащая рифампицин, изониазид, этамбутол и пиразинамид, и способ ее получения |
| RU2682178C2 (ru) | 2013-07-26 | 2019-03-15 | Санофи | Противотуберкулезная стабильная фармацевтическая композиция в форме таблетки с покрытием, содержащей гранулированный изониазид и гранулированный рифапентин, и способ ее приготовления |
-
2014
- 2014-07-22 MX MX2016001155A patent/MX2016001155A/es unknown
- 2014-07-22 JP JP2016528510A patent/JP2016539110A/ja not_active Ceased
- 2014-07-22 SG SG10201803996WA patent/SG10201803996WA/en unknown
- 2014-07-22 AU AU2014295099A patent/AU2014295099B2/en not_active Revoked
- 2014-07-22 RU RU2016106328A patent/RU2694056C2/ru not_active IP Right Cessation
- 2014-07-22 SG SG11201510732VA patent/SG11201510732VA/en unknown
- 2014-07-22 EP EP14741647.3A patent/EP3024444A1/en not_active Withdrawn
- 2014-07-22 US US14/906,885 patent/US9814680B2/en not_active Expired - Fee Related
- 2014-07-22 CN CN201480041954.5A patent/CN105407876B/zh not_active Withdrawn - After Issue
- 2014-07-22 WO PCT/EP2014/065762 patent/WO2015011162A1/en active Application Filing
- 2014-07-22 CA CA2918528A patent/CA2918528A1/en not_active Withdrawn
- 2014-07-22 PE PE2016000090A patent/PE20160245A1/es unknown
- 2014-07-25 TW TW103125582A patent/TWI630911B/zh active
-
2015
- 2015-12-28 IL IL243369A patent/IL243369A0/en unknown
-
2016
- 2016-01-06 ZA ZA2016/00110A patent/ZA201600110B/en unknown
- 2016-01-19 PH PH12016500119A patent/PH12016500119A1/en unknown
- 2016-01-21 SA SA516370446A patent/SA516370446B1/ar unknown
- 2016-01-22 CL CL2016000183A patent/CL2016000183A1/es unknown
- 2016-06-15 HK HK16106876.8A patent/HK1218861A1/zh unknown
-
2018
- 2018-04-04 JP JP2018072182A patent/JP6476331B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PE20160245A1 (es) | 2016-05-10 |
| MX2016001155A (es) | 2016-04-29 |
| TWI630911B (zh) | 2018-08-01 |
| IL243369A0 (en) | 2016-02-29 |
| RU2016106328A (ru) | 2017-08-31 |
| SA516370446B1 (ar) | 2018-09-13 |
| WO2015011162A1 (en) | 2015-01-29 |
| AU2014295099B2 (en) | 2019-07-11 |
| RU2694056C2 (ru) | 2019-07-09 |
| AU2014295099A1 (en) | 2016-02-11 |
| JP2018123147A (ja) | 2018-08-09 |
| JP2016539110A (ja) | 2016-12-15 |
| HK1218861A1 (zh) | 2017-03-17 |
| TW201601723A (zh) | 2016-01-16 |
| JP6476331B2 (ja) | 2019-02-27 |
| CA2918528A1 (en) | 2015-01-29 |
| US9814680B2 (en) | 2017-11-14 |
| CN105407876A (zh) | 2016-03-16 |
| CL2016000183A1 (es) | 2016-07-01 |
| CN105407876B (zh) | 2019-08-30 |
| US20160184231A1 (en) | 2016-06-30 |
| SG11201510732VA (en) | 2016-01-28 |
| EP3024444A1 (en) | 2016-06-01 |
| ZA201600110B (en) | 2017-04-26 |
| PH12016500119A1 (en) | 2016-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015057451A5 (zh) | ||
| MX2016009427A (es) | Formulaciones de pridopidina de liberacion modificada. | |
| NZ593045A (en) | Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin-ii antagonist and/or a diuretic | |
| MA39765A (fr) | Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation | |
| SG10201805267UA (en) | Piperazine derivatives having multimodal activity against pain | |
| PH12015500823A1 (en) | Modified release formulations for oprozomib | |
| MX2018000546A (es) | Composiciones farmaceuticas que contienen celecoxib y tramadol. | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| MX2017013636A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas. | |
| SA516370446B1 (ar) | تركيبة صيدلانية مستقرة مضادة للدرن في صورة قرص قابل للتشتت يحتوي على حبيبات إيزونيازيد وحبيبات ريفابنتين، وعملية لتحضيرها | |
| MX2016008027A (es) | Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington. | |
| MX2017005163A (es) | Composiciones de liberación prolongada de onapristona y métodos. | |
| PH12016500120A1 (en) | Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation | |
| MX2017013633A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas. | |
| MX2018010065A (es) | Forma de dosificacion oral que comprende rifaximina en forma beta. | |
| MX2018011293A (es) | Composicion farmaceutica de liberacion prolongada que comprende cisteamina o sal de la misma. | |
| MX2017013643A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz. | |
| MX2017013634A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y un polvo. | |
| MX2015011099A (es) | Composiciones farmaceuticas de donepezilo que tienen un perfil de disolución in vitro o parámetros farmacocinéticos específicos. | |
| AU2017260751A1 (en) | Tablet-in-tablet pharmaceutical composition comprising cyclophosphamide and capecitabine | |
| IN2013MU02110A (zh) | ||
| IN2013MU02111A (zh) | ||
| UA97982U (uk) | Лікарський засіб седативної дії у вигляді таблеток | |
| IN2013MU02286A (zh) | ||
| IN2013MU01154A (zh) |